CareTrust REIT, Inc. (CTRE)
NYSE: CTRE · Real-Time Price · USD
28.69
-0.14 (-0.49%)
At close: Mar 26, 2025, 4:00 PM
28.40
-0.29 (-1.01%)
After-hours: Mar 26, 2025, 6:16 PM EST

Company Description

CareTrust REIT, Inc.’s (“CareTrust REIT” or the “Company”) primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector.

As of March 31, 2024, the Company owned directly or through a joint venture and leased to independent operators, 228 skilled nursing facilities (“SNFs”), multi-service campuses, assisted living facilities (“ALFs”) and independent living facilities (“ILFs”) consisting of 24,189 operational beds and units located in 29 states with the highest concentration of properties by rental income located in California and Texas.

As of March 31, 2024, the Company also had other real estate related investments consisting of one preferred equity investment, nine real estate secured loans receivable and four mezzanine loans receivable with a carrying value of $233.3 million.

CareTrust REIT, Inc.
CareTrust REIT logo
Country United States
Founded 2013
Industry REIT - Healthcare Facilities
Sector Real Estate
Employees 21
CEO David Sedgwick

Contact Details

Address:
905 Calle Amanecer, Suite 300
San Clemente, California 92673-6277
United States
Phone 949 542 3130
Website caretrustreit.com

Stock Details

Ticker Symbol CTRE
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001590717
CUSIP Number 14174T107
ISIN Number US14174T1079
Employer ID 46-3999490
SIC Code 6798

Key Executives

Name Position
David M. Sedgwick Chief Executive Officer, President and Director
William M. Wagner CPA Chief Financial Officer and Treasurer
James B. Callister Chief Investment Officer and Secretary
Lauren Beale Senior Vice President and Chief Accounting Officer
Eric Gillis Director of Asset Management
Tri Tran Senior Vice President of Investments
Michael Sotelo Controller

Latest SEC Filings

Date Type Title
Mar 11, 2025 8-K Current Report
Mar 7, 2025 ARS Filing
Mar 7, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 7, 2025 DEF 14A Other definitive proxy statements
Feb 12, 2025 8-K Current Report
Feb 12, 2025 10-K Annual Report
Feb 10, 2025 SCHEDULE 13G/A Filing
Jan 21, 2025 8-K Current Report
Jan 21, 2025 424B5 Filing
Jan 2, 2025 8-K Current Report